» Articles » PMID: 38789023

PTEN Inhibition Promotes Robust Growth of Bulbospinal Respiratory Axons and Partial Recovery of Diaphragm Function in a Chronic Model of Cervical Contusion Spinal Cord Injury

Overview
Journal Exp Neurol
Specialty Neurology
Date 2024 May 24
PMID 38789023
Authors
Affiliations
Soon will be listed here.
Abstract

High spinal cord injury (SCI) leads to persistent and debilitating compromise in respiratory function. Cervical SCI not only causes the death of phrenic motor neurons (PhMNs) that innervate the diaphragm, but also damages descending respiratory pathways originating in the rostral ventral respiratory group (rVRG) located in the brainstem, resulting in denervation and consequent silencing of spared PhMNs located caudal to injury. It is imperative to determine whether interventions targeting rVRG axon growth and respiratory neural circuit reconnection are efficacious in chronic cervical contusion SCI, given that the vast majority of individuals are chronically-injured and most cases of SCI involve contusion-type damage to the cervical region. We therefore employed a rat model of chronic cervical hemicontusion to test therapeutic manipulations aimed at reconstructing damaged rVRG-PhMN-diaphragm circuitry to achieve recovery of respiratory function. At a chronic time point post-injury, we systemically administered: an antagonist peptide directed against phosphatase and tensin homolog (PTEN), a central inhibitor of neuron-intrinsic axon growth potential; an antagonist peptide directed against receptor-type protein tyrosine phosphatase sigma (PTPσ), another important negative regulator of axon growth capacity; or a combination of these two peptides. PTEN antagonist peptide (PAP4) promoted partial recovery of diaphragm motor activity out to nine months post-injury (though this effect depended on the anesthetic regimen used during recording), while PTPσ peptide did not impact diaphragm function after cervical SCI. Furthermore, PAP4 promoted robust growth of descending bulbospinal rVRG axons caudal to the injury within the denervated portion of the PhMN pool, while PTPσ peptide did not affect rVRG axon growth at this location that is critical to control of diaphragmatic respiratory function. In conclusion, we find that, when PTEN inhibition is targeted at a chronic time point following cervical contusion, our non-invasive PAP4 strategy can successfully promote significant regrowth of damaged respiratory neural circuitry and also partial recovery of diaphragm motor function.

References
1.
Danilov C, Steward O . Conditional genetic deletion of PTEN after a spinal cord injury enhances regenerative growth of CST axons and motor function recovery in mice. Exp Neurol. 2015; 266:147-60. PMC: 4382431. DOI: 10.1016/j.expneurol.2015.02.012. View

2.
Ohtake Y, Park D, Abdul-Muneer P, Muneer P, Li H, Xu B . The effect of systemic PTEN antagonist peptides on axon growth and functional recovery after spinal cord injury. Biomaterials. 2014; 35(16):4610-26. PMC: 4195449. DOI: 10.1016/j.biomaterials.2014.02.037. View

3.
Tashiro S, Nakamura M, Okano H . The prospects of regenerative medicine combined with rehabilitative approaches for chronic spinal cord injury animal models. Neural Regen Res. 2017; 12(1):43-46. PMC: 5319231. DOI: 10.4103/1673-5374.198972. View

4.
Charsar B, Brinton M, Locke K, Chen A, Ghosh B, Urban M . AAV2-BDNF promotes respiratory axon plasticity and recovery of diaphragm function following spinal cord injury. FASEB J. 2019; 33(12):13775-13793. PMC: 6894085. DOI: 10.1096/fj.201901730R. View

5.
Wollman L, Streeter K, Fuller D . Ampakine pretreatment enables a single brief hypoxic episode to evoke phrenic motor facilitation. J Neurophysiol. 2020; 123(3):993-1003. PMC: 7099472. DOI: 10.1152/jn.00708.2019. View